IL-23 has been established as a key player in the pathogenesis of psoriasis by promoting the generation of pathogenic Th17 and IL-17-producing γδ T cells [1, 2, 4], which can be synergized upon combination with IL-1β [17–21]. Here, IL1B is linked to psoriasis.